K130235 is an FDA 510(k) clearance for the SURFUSE II GEL, SURFUSE II PUTTY, EXFUSE II GEL, EXFUSE II PUTTY. Classified as Bone Grafting Material, Human Source (product code NUN), Class II - Special Controls.
Submitted by Hans Biomed Corp. (Chevy Chase, US). The FDA issued a Cleared decision on January 10, 2014 after a review of 345 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3930 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.
View all Hans Biomed Corp. devices